In this project, the team is building on previous work profiling short pieces of genetic code, called microRNAs, in the blood of children being treated for cancer. They are now testing whether measurement of specific microRNAs in blood samples can be used to accurately assess response to treatment in common childhood cancers such as neuroblastoma, Wilms’ tumour and lymphoma.
The genetics of familial leukaemia
Professor Nicholas Coleman
University of Cambridge
Cambridge, CB2 1TN
1 October 2012